SLFN5 and cancer: It has been found recently that human SLFN5 can inhibit ZEB1 transcription by directly binding to the SLFN5 binding motif on the ZEB1 promoter, thereby maintaining the epithelial cell morphology and inhibiting metastasis in BRCA mutant cancer cells [69,70].